Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 3:12:1462841.
doi: 10.3389/fcell.2024.1462841. eCollection 2024.

Lung epithelial-endothelial-mesenchymal signaling network with hepatocyte growth factor as a hub is involved in bronchopulmonary dysplasia

Affiliations
Review

Lung epithelial-endothelial-mesenchymal signaling network with hepatocyte growth factor as a hub is involved in bronchopulmonary dysplasia

Yating Sang et al. Front Cell Dev Biol. .

Abstract

Bronchopulmonary dysplasia (BPD) is fundamentally characterized by the arrest of lung development and abnormal repair mechanisms, which result in impaired development of the alveoli and microvasculature. Hepatocyte growth factor (HGF), secreted by pulmonary mesenchymal and endothelial cells, plays a pivotal role in the promotion of epithelial and endothelial cell proliferation, branching morphogenesis, angiogenesis, and alveolarization. HGF exerts its beneficial effects on pulmonary vascular development and alveolar simplification primarily through two pivotal pathways: the stimulation of neovascularization, thereby enriching the pulmonary microvascular network, and the inhibition of the epithelial-mesenchymal transition (EMT), which is crucial for maintaining the integrity of the alveolar structure. We discuss HGF and its receptor c-Met, interact with various growth factors throughout the process of lung development and BPD, and form a signaling network with HGF as a hub, which plays the pivotal role in orchestrating and integrating epithelial, endothelial and mesenchymal.

Keywords: angiogenesis; bronchopulmonary dysplasia (BPD); epithelial-mesenchymal transition (EMT); growth factors; hepatocyte growth factor (HGF).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Hepatocyte Growth Factor (HGF) Signaling Pathway in Alveolar Epithelial cells (AECs) and Endothelial Cells (ECs) in Lung Development. HGF, partly secreted by ECs, through paracrine and autocrine mechanisms, binds to the c-Met receptor on AECs and ECs. This interaction triggers a cascade of downstream signaling molecules that primarily promote cell proliferation and anti-apoptotic effects. Additionally, HGF regulates cytoskeletal dynamics, cellular migration, and morphogenesis by activating Rho and FAK (By Figdraw).
FIGURE 2
FIGURE 2
The Role of HGF in the Crosstalk between Lung Mesenchyme-Endothelium-Epithelium. HGF, derived from endothelial cells, activates the Rap1 signaling pathway, recruiting myofibroblasts (MYF) and promoting the deposition of extracellular matrix (ECM) proteins, including elastin and collagen. Increased ECM stiffness, through mechanosignaling, leads to the dephosphorylation and activation of YAP/TAZ, thereby stimulating the secretion of HGF by myofibroblasts (MYFs). Hyperoxia upregulates the expression of TGFβ, which promotes epithelial-mesenchymal transition (EMT) in epithelial cells. HGF inhibits the occurrence of EMT by antagonizing the expression of TGFβ and degrading ECM-related proteins (By Figdraw).

Similar articles

Cited by

References

    1. Abman S. H. (2001). Bronchopulmonary dysplasia: a vascular hypothesis. Am. J. Respir. Crit. care Med. 164 (10 Pt 1), 1755–1756. 10.1164/ajrccm.164.10.2109111c - DOI - PubMed
    1. Ahn S. Y., Chang Y. S., Sung D. K., Yoo H. S., Sung S. I., Choi S. J., et al. (2015). Cell type-dependent variation in paracrine potency determines therapeutic efficacy against neonatal hyperoxic lung injury. Cytotherapy 17 (8), 1025–1035. 10.1016/j.jcyt.2015.03.008 - DOI - PubMed
    1. Aly H., Mansi Y., Ez El Din Z., Gabr Metwally H., Sabry A. (2019). Mesenchymal stromal cells and TGF-β1 in tracheal aspirate of premature infants: early predictors for bronchopulmonary dysplasia? J. Perinat. Med. 47 (4), 470–477. 10.1515/jpm-2018-0305 - DOI - PubMed
    1. Appuhn S. V., Siebert S., Myti D., Wrede C., Surate Solaligue D. E., Pérez-Bravo D., et al. (2021). Capillary changes precede disordered alveolarization in a mouse model of bronchopulmonary dysplasia. Am. J. Respir. cell Mol. Biol. 65 (1), 81–91. 10.1165/rcmb.2021-0004OC - DOI - PubMed
    1. Arjaans S., Wagner B. D., Mourani P. M., Mandell E. W., Poindexter B. B., Berger R. M. F., et al. (2020). Early angiogenic proteins associated with high risk for bronchopulmonary dysplasia and pulmonary hypertension in preterm infants. Am. J. physiology. Lung Cell. Mol. physiology 318 (4), L644–L654. 10.1152/ajplung.00131.2019 - DOI - PMC - PubMed

LinkOut - more resources